“The Proof is in the Pudding”: Do SGLT2 Inhibitors Cause Diabetic Ketoacidosis?

Elena Barengolts, MD

AACE Clinical Case Reports (Mar 2018)

“The Proof is in the Pudding”: Do SGLT2 Inhibitors Cause Diabetic Ketoacidosis?

Elena Barengolts, MD

Affiliations

Elena Barengolts, MD: From the Endocrinology, Diabetes and Metabolism Unit, University of Illinois at Chicago and the Jesse Brown VA Medical Center, Chicago, Illinois.; Address correspondence to Dr. Elena Barengolts, University of Illinois at Chicago and Jesse Brown VA Medical Center, Endocrinology, Diabetes and Metabolism Unit, 835 South Wolcott Street, 6th Floor, E625, Chicago, IL 60612.

Journal volume & issue: Vol. 4, no. 2
pp. 184 – 185

Abstract

Read online

Abbreviations: DKA diabetic ketoacidosis EuDKA euglycemic diabetic ketoacidosis SGLT2i sodium-glucose cotransporter 2 inhibitors T2DM type 2 diabetes mellitus

Published in AACE Clinical Case Reports

ISSN: 2376-0605 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://www.journals.elsevier.com/aace-clinical-case-reports

About the journal